# Statistical declarations versus scientific inferences and clinical judgments: the association of Glucagon-like peptide-1 receptor agonist use with the risk of biliary disease

**Authors:** David E. Most

PMC · DOI: 10.3389/fendo.2024.1367158 · Frontiers in Endocrinology · 2024-01-29

## Full-text entities

- **Diseases:** biliary disease (MESH:D001660)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10882269/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC10882269/full.md

---
Source: https://tomesphere.com/paper/PMC10882269